Barclays PLC decreased its holdings in US Physical Therapy, Inc. (NYSE:USPH – Free Report) by 5.4% during the third quarter, according to its latest Form 13F filing with the SEC. The company owned 7,054 shares of stock, after selling 399 shares during the period. Barclays PLC’s holdings in the U.S. Physical Therapy division were valued at $648,000 as of its latest filing with the SEC.
Several other institutional investors have also recently made changes to their holdings in USPH. BlackRock Inc. boosted his position in shares of US Physical Therapy by 9.3% in the 2nd quarter. BlackRock Inc. now owns 2,203,592 shares of the company’s stock valued at $267,494,000 after purchasing an additional 188,188 shares during the period. Kayne Anderson Rudnick Investment Management LLC boosted its position in US Physical Therapy by 0.9% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,509,045 shares of the company’s stock worth $183,183,000 after acquiring an additional 13,531 shares in the last quarter. Vanguard Group Inc. grew its holdings in the US Physical Therapy space by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 927,480 shares of the company’s stock valued at $92,238,000 after acquiring an additional 10,015 shares during the period. T. Rowe Price Investment Management Inc. lifted his position in shares of US Physical Therapy by 0.4% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 915,831 shares of the company’s stock worth $74,210,000 after acquiring an additional 3,618 shares in the last quarter. Finally, Copeland Capital Management LLC lifted its stake in shares of US Physical Therapy by 6.8% in the 3rd quarter. Copeland Capital Management LLC now owns 770,613 shares of the company’s stock valued at $70,688,000 after purchasing an additional 49,155 shares during the period.
Insider Trading in U.S. Physical Therapy
In other US Physical Therapy news, Director Clayton Trier sold 1,170 shares of the company’s stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $92.26, for a total transaction of $107,944.20. Following the completion of the sale, the director now owns 7,400 shares of the company’s stock, valued at approximately $682,724. The sale was disclosed in a document filed with the Securities and Exchange Commission, which can be accessed on the SEC’s website. 1.80% of the shares are owned by insiders.
Wall Street analysts predict growth
Several equity research analysts have recently commented on USPH stock. Barrington Research increased their target price on US Physical Therapy from $111.00 to $120.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 3rd. JPMorgan Chase & Co. cut their target price on shares of US Physical Therapy from $108.00 to $99.00 and gave the company an “overweight” rating in a research report on Friday, November 17th. One investment analyst has rated the stock as a “hold” and four have rated it a “buy.” According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $119.00.
Get the latest report on physical therapy in the US
US physical therapy stocks fell 0.2%
NYSE:USPH stock opened Friday at $101.92. The company has a debt-equity ratio of 0.29, a quick ratio of 2.77, and a current ratio of 2.77. US Physical Therapy Inc. has a 52-week low of $78.08 and a 52-week high of $124.11. His 50 day simple moving average for this company is $95.11 and his 200 day simple moving average is $93.27. The company has a market capitalization of $1.53 billion, a P/E ratio of 59.26x, a PEG ratio of 6.08x, and a beta of 1.36x.
About physical therapy in the United States
(Free report)
US Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related conditions, sports-related injuries, preventive care, injured worker rehabilitation, and neurological-related injuries. doing. .
read more
Curious if other hedge funds own USPH? Visit HoldingsChannel.com to get the latest 13F filing and insider transactions for US Physical Therapy, Inc. (NYSE:USPH – Free Report).
Receive news and reviews from US Physical Therapy Daily – Enter your email address below to receive a concise, daily summary of the latest news and analyst ratings for U.S. Physical Therapy and related companies in MarketBeat.com’s free daily email newsletter.
